刘茜,郭孟楠,赵辉,张旭,刘洋,邵馨
LIU Qian,GUO Meng-nan,ZHAO Hui,ZHANG Xu,LIU Yang,SHAO Xin(School of Pharmacy

• 1:沈阳药科大学药学院

摘要(Abstract)：

目的建立LC-MS/MS法测定人血浆中米格列奈的浓度,并研究其在健康男性受试者体内的药动学。方法血浆经液-液萃取。色谱柱:Agilent TC-C18柱,流动相:乙腈-水-甲酸(体积比为70.0∶30.0∶0.3),质谱检测采用多反应监测模式(multiple reaction monitoring,MRM),电喷雾离子源,分析时间:2.0 min。结果米格列奈线性为5.0～4 000.0μg.L-1,定量下限为5.0μg.L-1。日内、日间精密度(relative standard deviation,RSD)均不大于10.5%,准确度(relative error,RE)为-0.8%～-2.0%。健康男性受试者口服含米格列奈10 mg的受试制剂(规格:10 mg/片)和参比制剂(规格:5 mg/片)后主要药动学参数为:tmax分别为(0.375±0.079)和(0.396±0.166)h,ρmax分别为(887±292)和(902±298)μg.L-1,t1/2分别为(1.37±0.45)和(1.49±0.57)h,AUC0-t分别为(1047±379)和(1 067±430)μg.h.L-1,AUC0-∞分别为(1 070±394)和(1 092±433)μg.h.L-1。结论该法适用于米格列奈的药动学及生物等效性研究。
Objective To develop an LC-MS/MS method for the study of the pharmacokinetics of mitiglinide in healthy male Chinese volunteers.Methods Acidified plasma samples were processed by a simple liquid-liquid extraction.The chromatographic separation was performed on an Agilent TC-C18 column with a mobile phase of acetonitrile-water-formic acid solution(V∶ V∶ V=70.0∶ 30.0∶ 0.3).Analytes were detected with an API2000 triple quadrupole mass spectrometer equipped with an electrospray ionization source.The analysis time is 0.2 min.Results The linear calibration curve was obtained in the range of 5.0-4 000.0 μg · L-1 for mitiglinide.The lower limit of quantitation was 5.0 μg · L-1.The intra-day and inter-day precision(RSD) was less than 10.5%,and the accuracy(relative error) was within 98.0%-100.8%.The main pharmacokinetic paramaters of 10 mg and 5 mg test table were as follows:tmax were(0.375±0.079) and(0.396±0.166)h,ρmax were(887±292) and(902±298)μg · L-1,t1/2 were(1.37±0.45) and(1.49±0.57)h,AUC0-t were(1 047±379) and(1 067±430)μg · h · L-1,and AUC0-∞ were(1 070±394) and(1 092±433)μg · h · L-1.Conclusions The method is suitable for pharmacokinetics and bioequivalence study of mitiglinide,which is convenient,sensitive and specific.

关键词(KeyWords)： 米格列奈;串联质谱法;生物等效性
mitiglinide;tandem mass spectrometry;bioequivalence

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 刘茜,郭孟楠,赵辉,张旭,刘洋,邵馨
LIU Qian,GUO Meng-nan,ZHAO Hui,ZHANG Xu,LIU Yang,SHAO Xin(School of Pharmacy

DOI: 10.14066/j.cnki.cn21-1349/r.2012.03.016

参考文献(References)：

• [1]国家药典委员会.中华人民共和国药典:二部[M].北京:中国医药科技出版社,2010:附录173-176.
• [2]SHAH V P,MIDHA K K,FINDLAY J W,et al.Bioana-lytical method validation-A revisit with a decade of pro-gress[J].Pharm Res,2000,17:1551-1557.
• [3]WEN Jin-hua,,XIONG Yu-qing.SPE and LC-ESI-MSfor quantitative analysis of mitiglinide in human plasmain a bioequivalence study[J].Journal of Chromatogra-phy A,2009(70):1715-1719.
• [4]钟大放.以加权最小二乘法建立生物分析标准曲线的若干问题[J].药物分析杂志,1996,16(5):343-346.
• [5]刘婷立,冯婉玉,顾玲玲,等.HPLC-MS/MS法研究米格列奈片在健康人体内的药代动力学[J].药物分析杂志,2009,29(2):225-228.
• [6]梁嘉碧,田媛,冯文周,等.米格列奈片人体药动学研究[J].中国药学杂志,2009,44(19):1500-1503.
• [7]石小鹏,赵培西,丁莉坤,等.液相色谱-串联质谱法测定人血浆中米格列奈浓度及其药动学研究[J].中国新药与临床杂志,2008,27(6):407-411.
• [8]程钢,彭文兴,蔡立婧,等.固相萃取结合液-质联用测定人血浆中米格列奈钙的浓度及其药动学研究[J].中国医院药学杂志,2009,29(20):1730-1734.
• [9]李鹏飞,刘丽宏,马萍,等.LC-MS/MS法测定人血浆中米格列奈浓度[J].质谱学报,2009,30(2):94-98.
• [10]汪志娟,李见春,董海军,等.米格列奈钙片单、多次给药人体药代动力学研究[J].安徽医药,2009,13(9):1028-1031.